Dario Campana

Dario Campana is currently a Scientific Advisor at Nkarta. Prior to this, they worked as a Scientist at Stem CentRx from August 2010 to August 2014. There, they were responsible for early stage therapeutic ADC antibody generation and characterization, targeting cancer stem cells in solid tumors. Dario also discovered multiple CSC markers for pancreatic, ovarian and breast cancer indications.

Before working at Stem CentRx, Campana was a Scientist at OncoMed Pharmaceuticals from January 2005 to July 2010, where they specialized in flow cytometry and hybridoma development. From November 2003 to January 2005, they worked as a Senior Research Associate at Anosys. Dario began their career as a Research Associate at Maxygen in January 1998 and worked there until October 2002.

Dario Campana has a BA in Biology from the University of California, Santa Cruz.